Dignitana AB Publishes August Newsletter
Dignitana Release - wkr0006.pdf
Lund, Sweden – 10 August 2018 – Dignitana AB today publishes the August 2018 edition of the company newsletter.
The newsletter is attached here and posted at http://www.dignitana.se/newsletter/. The Dignitana IN BRIEF newsletter is published monthly for Dignitana shareholders. It is posted to the Dignitana website and is available by email subscription at http://eepurl.com/dwHiLf
Investor Relations
Melissa Bourestom, Dignitana, phone: 00 1 469 518 5031 email: investorrelations@dignitana.com
Dignitana AB is the world leader in clinically superior scalp cooling technology. The company produces The DigniCap® Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and acceptable patient comfort. Dignitana AB is listed on Nasdaq First North Stockholm in Sweden with headquarters in Lund, Sweden and operations based in Dallas, Texas in the United States. Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy. Erik Penser Bank is Certified Adviser. Learn more at www.dignitana.se and www.dignicap.com.
DigniCap long-term study demonstrates safety and efficacy of scalp cooling to reduce chemo hair loss
Dignitana expands customer service coverage in Europe with oneservice partnership
Dignitana expands partnership with Celeritas to improve scalp cooling technology available in Mexico
Dignitana announces proposal for Local Coverage Determination of scalp cooling therapy
Dignitana enters Hong Kong market with leading distributor Science International Corporation
Dignitana newsletter highlights growth, media coverage and exemplary customer satisfaction
Innovative treatment for hair loss from chemotherapy to be presented at Stora Aktiedagen